Elderberry for COVID-19

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Franklin Health Research Center, Franklin, TN
COVID-19+5 More
Elderberry - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to confirm and quantify the effects of ElderCraft® elderberry extract on immune health.

Eligible Conditions

  • COVID-19
  • Cold
  • influenza-like illness or flu-like symptoms
  • Flu caused by Influenza
  • Upper Respiratory Tract Infection

Treatment Effectiveness

Study Objectives

4 Primary · 10 Secondary · Reporting Duration: 13 weeks

13 weeks
Adverse Events
Duration of COVID-19
Duration of Upper Respiratory Events
Duration of influenza
Incidence of COVID-19
Incidence of Upper Respiratory Events
Incidence of Upper Respiratory Symptomatic Days
Incidence of influenza
Severity of COVID-19
Severity of influenza
Symptom Severity
baseline and 13 weeks
Cognitive Wellbeing
Digestive Health
Energy Levels
Sleep Quality
Stress Levels

Trial Safety

Trial Design

2 Treatment Groups

Intervention Arm
1 of 2
Placebo Arm
1 of 2
Experimental Treatment
Non-Treatment Group

420 Total Participants · 2 Treatment Groups

Primary Treatment: Elderberry · Has Placebo Group · N/A

Intervention Arm
DietarySupplement
Experimental Group · 1 Intervention: Elderberry · Intervention Types: DietarySupplement
Placebo Arm
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Elderberry
2011
N/A
~80

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 13 weeks
Closest Location: Franklin Health Research Center · Franklin, TN
Photo of tennessee 1Photo of tennessee 2Photo of tennessee 3
2022First Recorded Clinical Trial
3 TrialsResearching COVID-19
4 CompletedClinical Trials

Who is running the clinical trial?

Artemis InternationalUNKNOWN
1 Previous Clinical Trials
57 Total Patients Enrolled
IPRONAUNKNOWN
Franklin Health ResearchLead Sponsor
13 Previous Clinical Trials
2,831 Total Patients Enrolled
2 Trials studying COVID-19
147 Patients Enrolled for COVID-19

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to take oral supplements and willing to commit to taking 2 capsules a day for 3 months.
You are employed full time in an occupation with direct and prolonged exposure to the public (i.e
You are willing and able to comply with all study procedures and are available for the duration of the study.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.